Overview

Our Intellectual Property & Technology (IP&T) team can provide you with a comprehensive service across the complete suite of intellectual property rights (IPR), including contentious matters.

With experience across a diverse range of industries including pharmaceutical, engineering, media, financial services, mining, IT and biotechnology, we help our clients create, protect and commercialise their IPR, and avoid unauthorised use of third party rights.

Our track record includes advice to, and representation of, a wide range of clients from start-ups to large international household names, who value our ability to see the 'big picture'. Our experienced team, one of whom is the author of the trade marks and domains section of the leading IP information service, Lahore Patents, Trade Mark and Related Rights, are trusted advisors to clients such as Nine Entertainment Network Australia, Breville, Yamaha Motors Australia, Hoyts Corporation and the Royal Institution of Chartered Surveyors.

We can help with:

Drawing on a global network of professional associates, our IP&T experts can assist you across Australia and throughout the world.

Contacts
Senior Associate
T +61 2 8233 9589
 
Intellectual Property awards and rankings

Our IPT&C team have received many accolades for their expertise in Intellectual Property.

DibbsBarker ranked in Tier 3.
DibbsBarker ranked in Band 5, Scott Sloan ranked Band 4 and Rob McInnes noted.
DibbsBarker ranked in both ‘Enforcement & Litigation’ and ‘Prosecution & Strategy’ categories. Stuart Green, Melissa McGrath and Scott Sloan individually ranked.

DibbsBarker listed as recommended in ‘Transactions’ ranked bronze in ‘Litigation’. Rob McInnes, Melissa McGrath and Scott Sloan individually ranked.

DibbsBarker listed as a notable firm in both patent contentious and trade mark contentious.
 
 
Recent News and Publications
20 Apr 2017
In a recent appeal case heard by the Full Court of the Federal Court of Australia, the Court has confirmed that merely making an application for listing of a patented pharmaceutical product on the Pharmaceutical Benefits Scheme (PBS) would not infringe the patent.
06 Apr 2017
Australia’s current insolvent trading laws and lack of protection against ‘ipso facto’ clauses can make certain restructurings and workouts far more difficult than they need to be.
28 Mar 2017
As China’s trade mark system operates on a ‘first to file’ basis, foreign brand owners that do not register their own marks can often come up against ‘trade mark squatters’ who secure a registration before the brand owner, and who sometimes seek to sell it to the brand owner at significant cost.